Cardiac Resynchronization Therapy Devices
-
Subject Areas on Research
-
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
-
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
-
Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices.
-
Atrial fibrillation in heart failure: what should we do?
-
Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
-
Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
-
Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
-
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
-
Extraction of chronically implanted coronary sinus leads active fixation vs passive fixation leads.
-
Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks.
-
Follow-up of patients with new cardiovascular implantable electronic devices: are experts' recommendations implemented in routine clinical practice?
-
Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?
-
How to Implant Cardiac Resynchronization Therapy in a Busy Clinical Practice.
-
ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.
-
Impact of using a telescoping-support catheter system for left ventricular lead placement on implant success and procedure time of cardiac resynchronization therapy.
-
Left Bundle Branch Block: Is it "Unsafe at Any Speed"?
-
Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy.
-
More bad news for cardiac resynchronization therapy in atrial fibrillation patients: what to do?
-
Navigating Choices Among a Sea of Comorbidities.
-
Non-invasively quantified changes in left ventricular activation predict outcomes in patients undergoing cardiac resynchronization therapy.
-
Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
-
Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.
-
PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
-
Performance of a novel active fixation quadripolar left ventricular lead for cardiac resynchronization therapy: Attain Stability Quad Clinical Study results.
-
Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
-
QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.
-
Remote monitoring of cardiac implantable electronic devices (CIED).
-
Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities.
-
Response to letter regarding, "PR interval identifies clinical response in patients with non-left bundle branch block: a multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy sub-study" by Kutyifa et al.
-
Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure.
-
Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities.
-
Scar burden assessed by Selvester QRS score predicts prognosis, not CRT clinical benefit in preventing heart failure event and death: A MADIT-CRT sub-study.
-
Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT.
-
Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
-
The ABCs of managing systolic heart failure: Past, present, and future.
-
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review.
-
The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring.
-
Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.
-
Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators.
-
Wireless, battery-free, fully implantable multimodal and multisite pacemakers for applications in small animal models.
-
Keywords of People